C06OD032081
Project Grant
Overview
Grant Description
Modernization and Expansion of the University of Illinois at Chicago Animal-Based Research Program - Abstract
The University of Illinois at Chicago (UIC) has developed highly recognized programs in health disparity research and is a national leader among urban, public institutions that provide care for diverse patient populations through its hospital and community-based clinical systems.
Our UIC research programs have developed around our diverse populations and communities with a focus on understanding disease mechanisms, developing novel therapeutics, and refining clinical approaches that have relevance to our patient base. Our preclinical modeling capability and laboratory animal research facilities now require expansion to link our research opportunities with the capability to generate and characterize models of human disease that support our core mission areas.
UIC proposes to modernize and expand its animal-based research programs by performing critical renovations to the Biologic Resources Laboratory (BRL), the institution's centralized animal facility. The project will comprise renovations and upgrades to essential elements of the heating, ventilation, and air conditioning (HVAC) and electrical systems in the BRL to increase housing capacity and accommodate growth in the institution's murine-based cancer and metabolic research programs.
These include a patient-derived organoid and xenograft modeling core that uses samples from underrepresented cancer patient populations and a new metabolic disease core to model health disparities in the treatment of cardiovascular and metabolic diseases. Such modernization will also result in significant energy efficiencies.
Overall, UIC BRL improvements will support animal-based research and permit the expansion of our translational and clinical research programs in health disparities and drug discovery. The long-term impact of the UIC BRL expansion will sustain our programs of translational excellence in health disparities research and drug discovery while permitting the growth of our NIH-funded population-based research programs (All of Us within the Illinois Precision Medicine Consortium, UIC Institute for Minority Health Research, and our CTSA-supported Center for Clinical and Translational Sciences) and our UI Cancer Center. This expansion will also impact the research programs of our regional partners who rely upon our facilities, cores, and capability in animal research.
Finally, our entrepreneurship-based strategic plan and for-profit partnerships to drive drug discovery initiatives have also compelled the expansion of our animal-based preclinical modeling capabilities.
The University of Illinois at Chicago (UIC) has developed highly recognized programs in health disparity research and is a national leader among urban, public institutions that provide care for diverse patient populations through its hospital and community-based clinical systems.
Our UIC research programs have developed around our diverse populations and communities with a focus on understanding disease mechanisms, developing novel therapeutics, and refining clinical approaches that have relevance to our patient base. Our preclinical modeling capability and laboratory animal research facilities now require expansion to link our research opportunities with the capability to generate and characterize models of human disease that support our core mission areas.
UIC proposes to modernize and expand its animal-based research programs by performing critical renovations to the Biologic Resources Laboratory (BRL), the institution's centralized animal facility. The project will comprise renovations and upgrades to essential elements of the heating, ventilation, and air conditioning (HVAC) and electrical systems in the BRL to increase housing capacity and accommodate growth in the institution's murine-based cancer and metabolic research programs.
These include a patient-derived organoid and xenograft modeling core that uses samples from underrepresented cancer patient populations and a new metabolic disease core to model health disparities in the treatment of cardiovascular and metabolic diseases. Such modernization will also result in significant energy efficiencies.
Overall, UIC BRL improvements will support animal-based research and permit the expansion of our translational and clinical research programs in health disparities and drug discovery. The long-term impact of the UIC BRL expansion will sustain our programs of translational excellence in health disparities research and drug discovery while permitting the growth of our NIH-funded population-based research programs (All of Us within the Illinois Precision Medicine Consortium, UIC Institute for Minority Health Research, and our CTSA-supported Center for Clinical and Translational Sciences) and our UI Cancer Center. This expansion will also impact the research programs of our regional partners who rely upon our facilities, cores, and capability in animal research.
Finally, our entrepreneurship-based strategic plan and for-profit partnerships to drive drug discovery initiatives have also compelled the expansion of our animal-based preclinical modeling capabilities.
Awardee
Grant Program (CFDA)
Awarding Agency
Place of Performance
Chicago,
Illinois
60612
United States
Geographic Scope
Single Zip Code
Related Opportunity
University Of Illinois was awarded
UIC Animal-Based Research Program Expansion
Project Grant C06OD032081
worth $6,749,090
from the National Institute of Allergy and Infectious Diseases in September 2021 with work to be completed primarily in Chicago Illinois United States.
The grant
has a duration of 4 years 8 months and
was awarded through assistance program 93.352 Construction Support.
The Project Grant was awarded through grant opportunity Biomedical Research Facilities (C06 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 7/5/22
Period of Performance
9/20/21
Start Date
5/31/26
End Date
Funding Split
$6.7M
Federal Obligation
$0.0
Non-Federal Obligation
$6.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to C06OD032081
Additional Detail
Award ID FAIN
C06OD032081
SAI Number
C06OD032081-1703751934
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75AGNA NIH AGGREGATE FINANCIAL ASSISTANCE DATA AWARDING OFFICE
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
W8XEAJDKMXH3
Awardee CAGE
1YGW1
Performance District
07
Senators
Richard Durbin
Tammy Duckworth
Tammy Duckworth
Representative
Danny Davis
Modified: 7/5/22